About this trial
Pulmonary rehabilitation is an integral part of care for patients with chronic respiratory diseases. It improves patients' physical capacities, quality of life and symptoms, at least in the short term.
The hypothesis that patients receiving personalized support from a professional following pulmonary rehabilitation will maintain long-term benefits.
This study concerns patients with a diagnosis of one or more chronic respiratory diseases.
It is a multicenter, blinded, randomized controlled superiority trial in 2 parallel arms:
* a group comparing follow-up and personalized support after a pulmonary rehabilitation program (experimental group) * a control group receiving only usual care
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of one or more chronic respiratory diseases (asthma, chronic obstructive pulmonary disease, diffuse interstitial lung disease, bronchiectasis, obstructive sleep apnea syndrome, etc.).
Participation in a respiratory pulmonary program
Have given consent
Patient of legal age
Disqualifiers
Any medical contraindication to the practice of adapted physical activity in rehabilitation
Patients under guardianship or curatorship
Patients deprived of their liberty
Patients over 80 years of age at the time of inclusion.
Trial design
Parallel
Treatments tested in this trial
Personalized follow-up and support
Other interventionAfter a pulmonary rehabilitation program, an interview with a professional will enable the professional to identify the barriersand enablers of physical activity engagement, and to identify (with the patient) a plan for maintaining a physical activities adapted in daily life. Adapted solutions will then be proposed.
Treatment groups
Trial outcomes
Primary outcomes
Difference in average number of daily steps
The difference in average daily steps measured by accelerometry (over 7 days) at the end of the pulmonary rehabilitation course (V1) and after 24 months of personalized follow-up (V5).
Secondary outcomes
Cost-utility comparison between the two groups
The cost-utility comparison between the two groups at 24 months was carried out by means of a medico-economic evaluation. This evaluation contains 5 items : direct medical costs; costs of care in the experimental group; incremental cost-utility ratio at 24 months; medical indicator results measured in QALYs and health-related quality of life.
Comparison of changes in physical activity levels between the two groups
the evolution of physical activity levels is assessed with levels of activity : * Sedentary time (min/day) * Time spent in activity with light intensity (min/day) * Time spent in activity with moderate intensity (min/day) * Time spent in activity with vigorous intensity (min/day)
Comparison of changes in physical capacities between the two groups
The evolution of physical capacities is assessed with walking distance measured in the 6-minute walk test. The 6-minute walk test: total walked distance (in metres). The test will be performed twice, the best performance will be kept as reference value.
Comparison of changes in physical capacities between the two groups
The evolution of physical capacities is assessed with the endurance time on ergocycle at 80% of peak power, in seconds.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.